Marco Zaccaria: 3 Essential Steps to Manage Uterine Fibroids!
Marco Zaccaria, Global Product Manager at ESGE European Society Gynecology Endoscopy, shared a post on LinkedIn:
“During Uterine Fibroids Awareness Month, it is essential that every patient be aware of the steps to take to manage this benign gynecological condition!
First Step: Diagnosis
For many women, a fibroid diagnosis brings more questions than answers What are fibroids ?s Why did they develop? Do they explain my symptoms? And perhaps the biggest question….
Second Step: Understanding your options
A fibroid diagnosis is not a treatment plan. Today’s treatment landscape includes medication, minimally invasive procedures, uterus-preserving surgeries, and more
Understanding the differences is the first step toward making an informed decision
Third Step: Finding the Right Plan
The best treatment isn’t the newest or the most common What’s ‘best’ isn’t the same for everyone:
The right treatment depends on many personal factors, including your symptoms, the size and location of your fibroids, your age, your fertility goals, your overall health, your recovery preferences, and more.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 7, 2026, 19:12Why Does Fertility Change After 38? – Fertility Plus
-
Aug 7, 2026, 19:01Sean Lauber: Does Sex Before or After Embryo Transfer Affect Implantation or Pregnancy?
-
Aug 7, 2026, 18:53Kiani Davis: What I Would Start With in the Fertility Patient Journey
-
Aug 7, 2026, 18:41Dalia Majedi: Key Factors in Choosing an IVF Clinic Abroad
-
Aug 7, 2026, 18:32Sarah Lewen: Carousel Fertility Is Built to Help Clinics Win the Next Decade
-
Aug 7, 2026, 18:14Masoud Zamani Esteki: The Key Knowledge Gaps in Modern Ovarian Biology
-
Aug 7, 2026, 18:01Jenny Gudge: New Opportunity for a Senior Fertility Nurse in Sussex
-
Aug 7, 2026, 17:37Clare Mansfield: I Don’t Think the Future of Fertility Care is Simply More Technology
-
Aug 7, 2026, 17:30Nevena Vidakovic: Reimagining the Future of Fertility at Merck
